In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
74 Xie, Y
therapies are largely symptomatic and directed at palliation rather than correction of the underlying immune dysfunction
However, the heterogeneity in study designs, populations, and covariates underscores the need for larger, longitudinal, and mechanistically focused investigations to fully elucidate the epigenetic consequences of NSW exposure and deriving health issues
PMID: 47 ZhouLTanJHZhouWYXuJRenSJLinZYet al
GMP AND ISO 9001: CARNI BEST manufacturing is backed by ISO-9001 and GMP (Good Manufacturing Practices) standards